Laboratory Historical Income Statement

LH Stock

USD 241.16 0.99 0.41%

Historical analysis of Laboratory income statement accounts such as Operating Income of 820.1 M, EBIT of 845.9 M or Ebitda of 1.1 B can show how well Laboratory of performed in making a profits. Evaluating Laboratory income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Laboratory's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Laboratory latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Laboratory is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Laboratory Income Statement Analysis

Laboratory Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Laboratory shareholders. The income statement also shows Laboratory investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Laboratory Income Statement Chart

As of now, Laboratory's EBIT is increasing as compared to previous years. The Laboratory's current Depreciation And Amortization is estimated to increase to about 606.2 M, while Gross Profit is projected to decrease to under 2 B.

Total Revenue Operating Income Ebitda Total Other Income Expense Net Selling General Administrative

Total Revenue

Total revenue comprises all receipts Laboratory generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Operating Income

Operating Income is the amount of profit realized from Laboratory operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Laboratory of is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Laboratory's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Laboratory current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2021	2022	2023	2024 (projected)
Gross Profit	5.6B	4.4B	3.4B	2.0B
Total Revenue	16.1B	14.9B	12.2B	12.8B

Gross Profit Total Revenue

Laboratory income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Operating Income	Ebit	Ebitda	Depreciation And Amortization	Other Operating Expenses	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Minority Interest	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.77	0.64	0.42	0.45	0.56	0.8	0.79	0.78	0.79	0.39	-0.34	0.43	0.17	0.78	-0.17	0.27	0.59	0.44	0.07	-0.51	-0.15	0.32	-0.49
Total Revenue	0.77		0.87	0.73	0.69	0.77	0.93	0.99	0.99	0.86	0.72	-0.57	0.74	0.44	0.85	-0.2	0.52	0.23	0.61	0.39	-0.85	0.29	0.76	-0.81
Gross Profit	0.64	0.87		0.91	0.88	0.93	0.83	0.8	0.82	0.92	0.89	-0.49	0.9	0.6	0.86	-0.07	0.5	0.22	0.37	0.46	-0.61	0.26	0.6	-0.58
Operating Income	0.42	0.73	0.91		0.99	0.97	0.74	0.62	0.65	0.7	0.99	-0.38	0.97	0.73	0.57	0.01	0.55	0.05	0.29	0.65	-0.44	0.18	0.6	-0.49
Ebit	0.45	0.69	0.88	0.99		0.98	0.74	0.58	0.61	0.68	0.98	-0.29	0.96	0.74	0.56	0.01	0.54	0.09	0.31	0.66	-0.38	0.05	0.57	-0.45
Ebitda	0.56	0.77	0.93	0.97	0.98		0.83	0.68	0.71	0.76	0.96	-0.36	0.95	0.69	0.65	0.01	0.54	0.14	0.37	0.62	-0.48	0.06	0.6	-0.53
Depreciation And Amortization	0.8	0.93	0.83	0.74	0.74	0.83		0.91	0.92	0.78	0.72	-0.55	0.74	0.44	0.75	-0.04	0.47	0.24	0.56	0.45	-0.78	0.11	0.73	-0.76
Other Operating Expenses	0.79	0.99	0.8	0.62	0.58	0.68	0.91		1.0	0.83	0.61	-0.56	0.64	0.34	0.84	-0.24	0.49	0.24	0.64	0.31	-0.88	0.29	0.76	-0.82
Cost Of Revenue	0.78	0.99	0.82	0.65	0.61	0.71	0.92	1.0		0.83	0.64	-0.56	0.67	0.37	0.83	-0.21	0.51	0.22	0.65	0.33	-0.87	0.28	0.76	-0.84
Total Operating Expenses	0.79	0.86	0.92	0.7	0.68	0.76	0.78	0.83	0.83		0.67	-0.44	0.71	0.36	0.98	-0.19	0.45	0.4	0.36	0.17	-0.59	0.16	0.44	-0.52
Income Before Tax	0.39	0.72	0.89	0.99	0.98	0.96	0.72	0.61	0.64	0.67		-0.33	0.97	0.76	0.55	-0.03	0.57	0.0	0.33	0.67	-0.43	0.17	0.62	-0.5
Total Other Income Expense Net	-0.34	-0.57	-0.49	-0.38	-0.29	-0.36	-0.55	-0.56	-0.56	-0.44	-0.33		-0.35	-0.19	-0.46	-0.33	-0.11	-0.22	-0.01	-0.22	0.6	-0.5	-0.57	0.5
Net Income	0.43	0.74	0.9	0.97	0.96	0.95	0.74	0.64	0.67	0.71	0.97	-0.35		0.58	0.6	-0.04	0.66	0.03	0.3	0.5	-0.48	0.14	0.61	-0.48
Income Tax Expense	0.17	0.44	0.6	0.73	0.74	0.69	0.44	0.34	0.37	0.36	0.76	-0.19	0.58		0.28	0.0	0.14	-0.09	0.32	0.93	-0.19	0.21	0.47	-0.39
Selling General Administrative	0.78	0.85	0.86	0.57	0.56	0.65	0.75	0.84	0.83	0.98	0.55	-0.46	0.6	0.28		-0.26	0.41	0.41	0.37	0.09	-0.66	0.24	0.47	-0.53
Minority Interest	-0.17	-0.2	-0.07	0.01	0.01	0.01	-0.04	-0.24	-0.21	-0.19	-0.03	-0.33	-0.04	0.0	-0.26		-0.47	-0.04	-0.14	0.05	0.22	-0.29	-0.24	-0.01
Net Income From Continuing Ops	0.27	0.52	0.5	0.55	0.54	0.54	0.47	0.49	0.51	0.45	0.57	-0.11	0.66	0.14	0.41	-0.47		0.0	0.24	0.15	-0.48	0.1	0.61	-0.35
Non Recurring	0.59	0.23	0.22	0.05	0.09	0.14	0.24	0.24	0.22	0.4	0.0	-0.22	0.03	-0.09	0.41	-0.04	0.0		-0.15	-0.18	-0.01	-0.09	-0.08	0.1
Non Operating Income Net Other	0.44	0.61	0.37	0.29	0.31	0.37	0.56	0.64	0.65	0.36	0.33	-0.01	0.3	0.32	0.37	-0.14	0.24	-0.15		0.37	-0.58	-0.05	0.51	-0.86
Tax Provision	0.07	0.39	0.46	0.65	0.66	0.62	0.45	0.31	0.33	0.17	0.67	-0.22	0.5	0.93	0.09	0.05	0.15	-0.18	0.37		-0.27	0.26	0.57	-0.47
Interest Income	-0.51	-0.85	-0.61	-0.44	-0.38	-0.48	-0.78	-0.88	-0.87	-0.59	-0.43	0.6	-0.48	-0.19	-0.66	0.22	-0.48	-0.01	-0.58	-0.27		-0.49	-0.84	0.82
Net Interest Income	-0.15	0.29	0.26	0.18	0.05	0.06	0.11	0.29	0.28	0.16	0.17	-0.5	0.14	0.21	0.24	-0.29	0.1	-0.09	-0.05	0.26	-0.49		0.5	-0.24
Reconciled Depreciation	0.32	0.76	0.6	0.6	0.57	0.6	0.73	0.76	0.76	0.44	0.62	-0.57	0.61	0.47	0.47	-0.24	0.61	-0.08	0.51	0.57	-0.84	0.5		-0.79
Extraordinary Items	-0.49	-0.81	-0.58	-0.49	-0.45	-0.53	-0.76	-0.82	-0.84	-0.52	-0.5	0.5	-0.48	-0.39	-0.53	-0.01	-0.35	0.1	-0.86	-0.47	0.82	-0.24	-0.79

Click cells to compare fundamentals

Laboratory Account Relationship Matchups

Laboratory income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	240.7M	207.4M	212.1M	180.3M	199.6M	209.6M
Total Revenue	11.6B	14.0B	16.1B	14.9B	12.2B	12.8B
Gross Profit	3.3B	5.0B	5.6B	4.4B	3.4B	2.0B
Operating Income	1.3B	2.4B	3.3B	1.8B	725.6M	820.1M
Ebit	1.3B	2.4B	3.3B	1.4B	768.5M	845.9M
Ebitda	2.0B	3.3B	4.3B	2.0B	1.3B	1.1B
Depreciation And Amortization	638.4M	825M	940M	537.2M	577.3M	606.2M
Other Operating Expenses	10.2B	11.0B	12.8B	12.7B	11.4B	12.0B
Cost Of Revenue	8.3B	9.0B	10.5B	10.5B	8.8B	9.2B
Total Operating Expenses	1.9B	2.0B	2.3B	2.3B	2.0B	1.1B
Income Before Tax	1.1B	2.2B	3.1B	1.6B	568.9M	748.7M
Total Other Income Expense Net	(225.3M)	(226.3M)	(132.9M)	(199.1M)	(156.7M)	(148.9M)
Net Income	823.8M	1.6B	2.4B	1.3B	418M	513.9M
Income Tax Expense	280M	662.1M	747.1M	302M	188.5M	233.9M
Selling General Administrative	1.6B	1.7B	2.0B	2.0B	2.2B	1.1B
Net Income Applicable To Common Shares	823.8M	(900K)	2.4B	1.3B	1.5B	1.5B
Minority Interest	20.1M	20.7M	(2.2M)	(1.5M)	(1.2M)	(1.1M)
Net Income From Continuing Ops	824.9M	(900K)	2.4B	1.3B	861.4M	880.6M
Tax Provision	280M	662.1M	747.1M	302M	210M	379.6M
Interest Income	212.3M	194.2M	175.4M	166M	149.4M	166.7M
Net Interest Income	(240.7M)	(207.4M)	(212.1M)	(180.3M)	(200.4M)	(210.4M)
Reconciled Depreciation	577.2M	624.7M	745.1M	633.9M	658M	679.5M

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.05)

Dividend Share

2.88

Earnings Share

5.28

Revenue Per Share

151.028

Quarterly Revenue Growth

0.074

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Historical Income Statement

About Laboratory Income Statement Analysis

Laboratory Income Statement Chart

Total Revenue

Operating Income

Laboratory income statement Correlations

Laboratory Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Laboratory income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Other Operating Expenses	+ 0.99	Total Revenue
Cost Of Revenue	+ 0.99	Total Revenue
Ebit	+ 0.99	Operating Income
Income Before Tax	+ 0.99	Operating Income
Ebitda	+ 0.98	Ebit

Interest Income	- 0.88	Other Operating Expenses
Interest Income	- 0.87	Cost Of Revenue
Extraordinary Items	- 0.86	Non Operating Income Net Other
Interest Income	- 0.85	Total Revenue
Reconciled Depreciation	- 0.84	Interest Income
Extraordinary Items	- 0.84	Cost Of Revenue